Nusinersen: the antisense oligonucleotide at the forefront of spinal muscular atrophy treatment. [PDF]
Singh NN, Ottesen EW, Singh RN.
europepmc +1 more source
Longitudinal multi-omics profiling of spinal muscular atrophy. [PDF]
Dabaj I +16 more
europepmc +1 more source
Unbiased bioinformatic and clinical analysis identifies glial fibrillary acidic protein as a potential biomarker in spinal muscular atrophy. [PDF]
Soares de Oliveira KL +12 more
europepmc +1 more source
Neonatal screening for spinal muscular atrophy: Report of a multicenter study in Brazil. [PDF]
Oliveira Netto AB +17 more
europepmc +1 more source
Strengthening adaptive functioning and participation in the contemporary spinal muscular atrophy paradigm: clinical perspectives and future directions. [PDF]
Farah EE +3 more
europepmc +1 more source
Behavioral barriers in the management of spinal muscular atrophy: The role of procrastination, regret, and burnout. [PDF]
Maurino J +5 more
europepmc +1 more source
Modeling the Budget Impact of Disease-Modifying Therapies in Infantile-Onset Spinal Muscular Atrophy. [PDF]
Abuloha S +4 more
europepmc +1 more source
Case Report: Presymptomatic risdiplam in preterm monozygotic twins with co-occurring spinal muscular atrophy and tuberous sclerosis complex. [PDF]
Zhang XF, Wang YJ, Li SX, Liu P, Hu WG.
europepmc +1 more source

